Published in J Virol on January 01, 2001
The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood (2011) 2.11
Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene (2005) 1.15
Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1. J Immunol (2006) 1.06
HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death. J Clin Invest (2006) 1.03
Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection. PLoS Pathog (2013) 0.97
Molecular determinants of human T-lymphotropic virus type 1 transmission and spread. Viruses (2011) 0.92
Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo. Retrovirology (2010) 0.90
Early and transient reverse transcription during primary deltaretroviral infection of sheep. Retrovirology (2008) 0.88
One-step, multiplex, real-time PCR assay with molecular beacon probes for simultaneous detection, differentiation, and quantification of human T-cell leukemia virus types 1, 2, and 3. J Clin Microbiol (2009) 0.87
Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication. Antimicrob Agents Chemother (2008) 0.83
Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL). Iran J Basic Med Sci (2013) 0.81
Mutation of a Single Envelope N-Linked Glycosylation Site Enhances the Pathogenicity of Bovine Leukemia Virus. J Virol (2015) 0.80
Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention. Bull Math Biol (2009) 0.80
Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection. Viral Immunol (2009) 0.79
Animal Models Utilized in HTLV-1 Research. Virology (Auckl) (2013) 0.77
Dynamics of perinatal bovine leukemia virus infection. BMC Vet Res (2014) 0.77
HTLV-1 ORF-I Encoded Proteins and the Regulation of Host Immune Response: Viral Induced Dysregulation of Intracellular Signaling. J Immunol Res (2015) 0.75
Endemic Viruses of Squirrel Monkeys (Saimiri spp.). Comp Med (2015) 0.75
A dose-effect relationship for deltaretrovirus-dependent leukemogenesis in sheep. Retrovirology (2009) 0.75
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet (1985) 13.47
HTLV-I associated myelopathy, a new clinical entity. Lancet (1986) 10.49
Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. Lancet (1994) 3.83
Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. J Biol Chem (1986) 3.48
Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol (1998) 3.32
Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet (1990) 2.96
Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood (1995) 2.19
Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol (1995) 1.95
Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol (1992) 1.94
Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood (2000) 1.87
HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J (1996) 1.69
Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb. Mol Cell Biol (1998) 1.66
Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J Virol (2000) 1.61
Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res (1997) 1.56
High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene (2000) 1.54
Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol (1991) 1.37
Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene (1998) 1.28
Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. Int J Cancer (1987) 1.18
Clonal expansion of infected cells: a way of life for HTLV-I. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.18
Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia. Am J Clin Pathol (1997) 1.18
Oral transmission of human T-cell leukemia virus type-I into a common marmoset (Callithrix jacchus) as an experimental model for milk-borne transmission. Jpn J Cancer Res (1985) 1.12
Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features. Arthritis Rheum (1991) 1.11
Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells. J Virol (1999) 1.04
Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood (1995) 1.03
Comparative biological responses of rabbits infected with human T-lymphotropic virus type I isolates from patients with lymphoproliferative and neurodegenerative disease. Int J Cancer (1992) 1.02
Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells. Blood (1996) 1.01
Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction. J Virol Methods (1998) 1.01
Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo. J Virol (2000) 1.01
Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma during immunosuppressive treatment following renal transplantation. Clin Infect Dis (1995) 1.01
Establishment of HTLV-I-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles. Virus Res (1993) 1.00
Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR. Res Virol (1995) 1.00
Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells in HTLV-1-associated myelopathy (HAM-TSP). Blood (1992) 0.98
Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood (1992) 0.97
Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene (1996) 0.97
Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies). J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.94
Human T lymphotropic virus type 1 uveitis. Br J Ophthalmol (1994) 0.92
Polymyositis in patients infected with human T-cell leukemia virus type I: the role of the virus in the cause of the disease. Ann Neurol (1994) 0.91
Molecular detection of pre-ATL state among healthy HTLV-1 carriers in an endemic area of Japan. Int J Cancer (1995) 0.87
Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene. J Gen Virol (1997) 0.87
Experimental inoculation of monkeys with autologous lymphoid cell lines immortalized by and producing human T-cell leukemia virus type-I. Int J Cancer (1986) 0.86
HTLV-I infection in squirrel monkeys (Saïmiri sciureus) using autologous, homologous, or heterologous HTLV-I-transformed cell lines. Virology (1997) 0.86
Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade. J Virol (2000) 0.86
Semiquantitative analysis of integrated genomes of human T-lymphotropic virus type I in asymptomatic virus carriers. Blood (1991) 0.86
Bilateral uveitis in a rabbit experimentally infected with human T-lymphotropic virus type I. Lab Invest (1993) 0.84
Adult T-cell leukemia developing during immunosuppressive treatment in a renal transplant recipient. Am J Hematol (1992) 0.83
HTLV-I associated primary CNS T-cell lymphoma. J Neurol Sci (1998) 0.83
Quantification of HTLV-1 proviral copy number in peripheral blood of symptomless carriers from the French West Indies. J Acquir Immune Defic Syndr (1992) 0.83
Transient adult T-cell leukemia/lymphoma picture during varicella infection in an HTLV-1 carrier. Leukemia (1994) 0.82
Oligoclonal proliferation of human T-cell leukaemia virus type 1 bearing T cells in adult T-cell leukaemia/lymphoma without deletion of the 3' provirus integration sites. Br J Haematol (1998) 0.81
Lymphocyte alveolitis in HAM/TSP patients. Preliminary report. Arq Neuropsiquiatr (1993) 0.78
Semiquantitative analysis of residual disease in patients treated for adult T-cell leukaemia/lymphoma (ATLL). Br J Haematol (1999) 0.78
Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood (1998) 2.71
Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst (2001) 1.64
High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene (2000) 1.54
Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature. Leukemia (1997) 1.50
Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood (1998) 1.42
Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia (2003) 1.39
Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation. J Clin Oncol (2000) 1.39
Inv(16) may be one of the only 'favorable' factors in acute myeloid leukemia: a report on 19 cases with prolonged follow-up. Leuk Res (1994) 1.39
Human T-cell lymphotropic virus type I and II DNA amplification in seropositive and seronegative at-risk individuals. Transfusion (1993) 1.38
Monkeys of the rainforest in French Guiana are natural reservoirs for P. brasilianum/P. malariae malaria. Parasitology (2000) 1.37
Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations. Leukemia (1995) 1.34
Dental age in Dutch children. Eur J Orthod (2005) 1.29
Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia (1993) 1.29
Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene (1998) 1.28
Mayaro virus fever in French Guiana: isolation, identification, and seroprevalence. Am J Trop Med Hyg (1998) 1.22
Is there still a role for low-dose cytosine arabinoside in de novo acute myeloid leukemia in the elderly? A report on 77 cases. Ann Hematol (1993) 1.11
An HTLV-I/II vaccine: from animal models to clinical trials? J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.07
Human impact on genetic diversity of Toxoplasma gondii: example of the anthropized environment from French Guiana. Infect Genet Evol (2011) 1.03
Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells. Blood (1996) 1.01
Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo. J Virol (2000) 1.01
Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR. Res Virol (1995) 1.00
Oncolytic activity of vesicular stomatitis virus in primary adult T-cell leukemia. Oncogene (2006) 0.99
Serologic survey of Toxoplasma gondii in noncarnivorous free-ranging neotropical mammals in French Guiana. Vector Borne Zoonotic Dis (2002) 0.98
patients with the description of a new scoring system and its validation on 253 other patients. Blood (2000) 0.98
Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene (1996) 0.97
Basis of HTLV type 1 target site selection. AIDS Res Hum Retroviruses (2000) 0.96
Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation schedule. Cancer Res (1988) 0.95
Wild terrestrial rainforest mammals as potential reservoirs for flaviviruses (yellow fever, dengue 2 and St Louis encephalitis viruses) in French Guiana. Trans R Soc Trop Med Hyg (2004) 0.95
Chronic myelomonocytic leukemia: from biology to therapy. Hematol Cell Ther (1997) 0.95
Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies). J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.94
p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood (1995) 0.93
Hepatitis viruses in non-human primates. J Med Primatol (2006) 0.93
Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes. Leukemia (1993) 0.91
The immunodominant Eimeria acervulina sporozoite antigen previously described as p160/p240 is a 19-kilodalton antigen present in several Eimeria species. Mol Biochem Parasitol (1994) 0.90
Health evaluation of translocated free-ranging primates in French Guiana. Am J Primatol (2001) 0.89
Glomerular injury in chronic myelomonocytic leukemia. Leuk Lymphoma (1995) 0.88
High prevalence of hepatitis C virus infection and predominance of genotype 4 in rural Gabon. J Med Virol (2008) 0.87
Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases. J Clin Oncol (1995) 0.87
Association of myelodysplastic syndrome and relapsing polychondritis: further evidence. Leukemia (1995) 0.86
Adult T cell leukaemia: a review of established and new treatments. BioDrugs (1998) 0.84
Adolescent growth changes in soft tissue profile. Am J Orthod Dentofacial Orthop (1995) 0.83
[Elements of epidemiology and initiation of carcinogenesis in carcinomas of the upper aerodigestive tract. Future therapeutic consequence?]. Rev Laryngol Otol Rhinol (Bord) (1999) 0.82
A distinct molecular variant of HTLV-IIB in Gabon, Central Africa. AIDS Res Hum Retroviruses (1994) 0.82
Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy. Br J Haematol (1996) 0.81
Rapid progression to AIDS in dual HIV-1/HTLV-I infection. Lancet (1990) 0.81
Hematological and serum chemistry profiles of free-ranging southern two-toed sloths in French Guiana. J Wildl Dis (1999) 0.81
Oligoclonal proliferation of human T-cell leukaemia virus type 1 bearing T cells in adult T-cell leukaemia/lymphoma without deletion of the 3' provirus integration sites. Br J Haematol (1998) 0.81
Vertical growth of the anterior face: a new approach. Am J Orthod Dentofacial Orthop (1992) 0.80
Good predictive value of combined cytogenetic and molecular follow up in chronic myelogenous leukemia after non T-cell depleted allogeneic bone marrow transplantation: a report on 38 consecutive cases. Leuk Lymphoma (1995) 0.80
Inactivation of the p53 gene in leukemias and myelodysplastic syndrome (MDS) with 17p monosomy. Leukemia (1994) 0.80
Comparison of injectable anesthetic combinations in free-ranging two-toed sloths in French guiana. J Wildl Dis (1998) 0.79
Vaccine against human T cell leukemia-lymphoma virus type I: progress and prospects. AIDS Res Hum Retroviruses (1996) 0.78
Molecular characterization of cDNAs encoding squirrel monkey (Saïmiri sciureus) CD8 alpha and beta chains. Immunogenetics (1999) 0.78
Human T cell lymphotropic virus: necessity for and feasibility of a vaccine. Ciba Found Symp (1994) 0.78
Inhibition of the hTERT promoter by the proto-oncogenic protein TAL1. Leukemia (2009) 0.78
Rare occurrence of mutations of the FLR exon of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) Leukemia (1993) 0.78
Evidence in Gabon for an intrafamilial clustering with mother-to-child and sexual transmission of a new molecular variant of human T-lymphotropic virus type-II subtype B. J Med Virol (1996) 0.78
All-trans retinoic acid in adult chronic myelomonocytic leukemia: results of a pilot study. Leukemia (1996) 0.78
First seroepidemiological study and phylogenetic characterization of human T-cell lymphotropic virus type I and II infection among Amerindians in French Guiana. J Gen Virol (1999) 0.78
Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients. Br J Haematol (1993) 0.78
Cytogenetic study in a bone marrow metastatic Merkel cell carcinoma. Cancer Genet Cytogenet (1991) 0.78
Prevalence of antibodies to hepatitis A, C, and E viruses in different ethnic groups in French Guiana. J Med Virol (1997) 0.78
Semiquantitative analysis of residual disease in patients treated for adult T-cell leukaemia/lymphoma (ATLL). Br J Haematol (1999) 0.78
Protective oral immunization of chickens against Eimeria tenella with sporozoite surface antigens. Vet Immunol Immunopathol (1993) 0.78
In vitro interactions between murine neutrophils and Eimeria falciformis sporozoites. Res Immunol (1993) 0.77
Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus). J Virol (2001) 0.77
Towards a new predictor of AIDS progression through the quantitation of HIV-1 DNA copies by PCR in HIV-infected individuals. Br J Haematol (1992) 0.77
Changes of mandibular ramal height, during growth in unilateral hemifacial microsomia patients and unaffected controls. J Craniomaxillofac Surg (2012) 0.77
Hematology and serum biochemistry values of free-ranging red howler monkeys (Alouatta seniculus) from French Guiana. J Zoo Wildl Med (1998) 0.77
A new method for locating anterior skeletal landmarks from soft tissue measurements. J Biol Buccale (1991) 0.76
[Dengue virus infection in neotropical forest mammals: incidental hosts or potential reservoirs?]. Med Trop (Mars) (2009) 0.76
[Infective dermatitis and recurrent strongyloidiasis in a child]. Ann Dermatol Venereol (2004) 0.76
Expression of the multidrug resistance-associated protein in myelodysplastic syndromes. Br J Haematol (2000) 0.76
Combined anti-fungal therapy and surgical resection as treatment of pulmonary zygomycosis in allogeneic bone marrow transplantation. Bone Marrow Transplant (1999) 0.76
A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients. Br J Haematol (1994) 0.76
Assessment of P-glycoprotein expression by immunocytochemistry and flow cytometry using two different monoclonal antibodies coupled with functional efflux analysis in 34 patients with acute myeloid leukemia. Adv Exp Med Biol (1999) 0.76
Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas. Eur J Nucl Med (1995) 0.75
Treatment with very low-dose GM-CSF in myelodysplastic syndromes with neutropenia. A report on 28 cases. Leukemia (1994) 0.75
[The role of the polymerase chain reaction (PCR) in the diagnosis of infection by HTLV-I/II virus]. Rev Fr Transfus Hemobiol (1991) 0.75
Dental development in hemifacial microsomia. J Dent Res (2010) 0.75
Polymerase chain reaction procedure for rapid diagnosis of HIV infection. AIDS (1993) 0.75
Craniofacial morphology in unilateral hemifacial microsomia. Br J Oral Maxillofac Surg (2012) 0.75
Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study. Leuk Lymphoma (1999) 0.75
Immobilization of free-ranging nine-banded and great long-nosed armadillos with three anesthetic combinations. J Wildl Dis (2000) 0.75
Chemotherapy of haemobartonellosis in squirrel monkeys (Saimiri sciureus). J Med Primatol (2000) 0.75
Assessment of volumetric changes with a best-fit method in three-dimensional stereophotograms. Cleft Palate Craniofac J (2011) 0.75
A new method for computer aided serial radiograph superimpositioning. Eur J Orthod (1985) 0.75
[Chronic myelomonocytic leukemia and Crohn disease]. Gastroenterol Clin Biol (1995) 0.75
Pharmacokinetics of 2-phenyl-1,3-indandione in the rat after i.v. and oral administration. Eur J Drug Metab Pharmacokinet (1979) 0.75
[Human and wild mammal parasitosis in French Guiana]. Med Trop (Mars) (2000) 0.75
Polymerase chain reaction (PCR) in various stages of HIV infection. Relationship to disease progression. Nouv Rev Fr Hematol (1991) 0.75
[Amyloidosis AL and chronic myelo-monocytic leukemia]. Ann Med Interne (Paris) (1994) 0.75
[Eimeria tenella and Eimeria acervulina: an antigenic stimulation in vitro of cells from immune chickens induced by adoptive transfer of protection against avian coccidiosis]. Vet Res (1993) 0.75
[Current knowledge on the action of retinoids in carcinoma of the head and neck]. Rev Laryngol Otol Rhinol (Bord) (1996) 0.75